Heres an overview of the most popular GLP-1 medications and their key features: Semaglutide (Brand names: Ozempic, Wegovy, Rybelsus Features: Once-weekly injection (Ozempic, Wegovy) or daily oral tablet (Rybelsus) Approved for type 2 diabetes (Ozempic, Rybelsus) and weight management (Wegovy) Benefits: Significant weight loss Improved glycemic control Cardiovascular benefits Liraglutide (Brand names: Victoza, Saxenda) Features: Daily injection Victoza approved for type 2 diabetes, Saxenda for weight management Benefits: Moderate weight loss Improved blood sugar control Cardiovascular benefits Dulaglutide (Brand name: Trulicity) Features: Once-weekly injection Approved for type 2 diabetes Benefits: Improved glycemic control Moderate weight loss Cardiovascular benefits Tirzepatide (Brand name: Mounjaro) Features: Once-weekly injection Approved for type 2 diabetes, under review for weight management Dual GIP and GLP-1 receptor agonist Benefits: Significant weight loss Improved glycemic control Potential cardiovascular benefits Key differences: Efficacy: Semaglutide and tirzepatide generally show the most significant weight loss and glycemic control improvements
SMSNA For Patients Fellowship RIGs
YOUNG: ...I feel like, at some point, you have to say
These dual actions diminish food cravings, slow down digestion, improve blood sugar control, and impact brain satisfaction centers more efficaciously
Hydration Water helps keep stool soft and easier to pass
It mainly activates the GIP receptor strongly but only partly activates the GLP-1 receptor, and it prefers certain signaling pathways over others
